John Roback to Humans
This is a "connection" page, showing publications John Roback has written about Humans.
Connection Strength
0.076
-
Convalescent Plasma to Treat COVID-19: Possibilities and Challenges. JAMA. 2020 04 28; 323(16):1561-1562.
Score: 0.007
-
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic. Transfus Med Rev. 2020 07; 34(3):145-150.
Score: 0.007
-
Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead. J Clin Microbiol. 2018 07; 56(7).
Score: 0.006
-
Current Evidence for the Use of Prophylactic Transfusion to Treat Sickle Cell Disease During Pregnancy. Transfus Med Rev. 2018 10; 32(4):220-224.
Score: 0.006
-
Impacts of New Concepts and Technologies on the Practice of Diagnostic Pathology: An Emory University Perspective. Arch Pathol Lab Med. 2017 03; 141(3):325-328.
Score: 0.006
-
Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience. Arch Pathol Lab Med. 2017 Mar; 141(3):329-340.
Score: 0.006
-
Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration. Sci Rep. 2021 07 16; 11(1):14604.
Score: 0.002
-
COVID-19 convalescent plasma donor recruitment experience from the perspective of a hospital transfusion medicine service. Transfusion. 2021 07; 61(7):2213-2215.
Score: 0.002
-
Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma. Transfusion. 2021 06; 61(6):1740-1748.
Score: 0.002
-
One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses. Immunohorizons. 2021 05 17; 5(5):322-335.
Score: 0.002
-
Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19. J Clin Microbiol. 2021 03 19; 59(4).
Score: 0.002
-
The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A. Blood Adv. 2021 03 09; 5(5):1305-1309.
Score: 0.002
-
An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay. Immunohematology. 2021 Mar; 37(1):33-43.
Score: 0.002
-
Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System. Ann Intern Med. 2021 05; 174(5):649-654.
Score: 0.002
-
Covid-19 will not "magically disappear": Why access to widespread testing is paramount. Am J Hematol. 2021 02 01; 96(2):174-178.
Score: 0.002
-
Therapeutic plasma exchange for COVID-19-associated hyperviscosity. Transfusion. 2021 04; 61(4):1029-1034.
Score: 0.002
-
Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity. Transfus Clin Biol. 2021 Feb; 28(1):51-54.
Score: 0.002
-
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease. Blood Adv. 2020 09 22; 4(18):4278-4281.
Score: 0.002
-
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020. Emerg Infect Dis. 2020 12; 26(12):2974-2978.
Score: 0.002
-
Anemia induces gut inflammation and injury in an animal model of preterm infants. Transfusion. 2019 04; 59(4):1233-1245.
Score: 0.002
-
Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants. Transfusion. 2019 05; 59(5):1675-1682.
Score: 0.002
-
Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease. Transfusion. 2019 02; 59(2):448-453.
Score: 0.002
-
Stability of anti-A blood group titers among blood group B renal transplant candidates. Transfusion. 2018 12; 58(12):2747-2751.
Score: 0.002
-
Does red blood cell irradiation and/or anemia trigger intestinal injury in premature infants with birth weight = 1250 g? An observational birth cohort study. BMC Pediatr. 2018 08 11; 18(1):270.
Score: 0.002
-
Trends in transfusion rates after the FOCUS trial. J Comp Eff Res. 2018 02; 7(2):113-120.
Score: 0.002
-
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 05; 24(5):973-982.
Score: 0.001
-
Cytomegalovirus-safe blood: the unclear effect of sickle hemoglobin. Transfusion. 2017 06; 57(6):1582-1583.
Score: 0.001
-
Daratumumab (anti-CD38) induces loss of CD38 on red blood cells. Blood. 2017 06 01; 129(22):3033-3037.
Score: 0.001